APO-CICLESONIDE SPRAY, METERED DOSE
Krajina: Kanada
Jazyk: angličtina
Zdroj: Health Canada
Súhrn charakteristických
(SPC)
01-09-2017
Niektoré dokumenty týkajúce sa tohto produktu nie sú momentálne k dispozícii, môžete poslať požiadavku na náš zákaznícky servis a my vás upozorníme hneď, ako ich dokážeme získať.
Poslať žiadosť.
Poslať žiadosť.
Aktívna zložka:
CICLESONIDE
Dostupné z:
APOTEX INC
ATC kód:
R01AD13
INN (Medzinárodný Name):
CICLESONIDE
Dávkovanie:
50MCG
Forma lieku:
SPRAY, METERED DOSE
Zloženie:
CICLESONIDE 50MCG
Spôsob podávania:
NASAL
Počet v balení:
120 METERED SPRAYS
Typ predpisu:
Prescription
Terapeutické oblasti:
CORTICOSTEROIDS
Prehľad produktov:
Active ingredient group (AIG) number: 0151669004; AHFS:
Stav Autorizácia:
APPROVED
Dátum Autorizácia:
2015-05-01
Súhrn charakteristických
PRODUCT MONOGRAPH
APO-CICLESONIDE
CICLESONIDE NASAL SPRAY
50 MCG/METERED SPRAY
CORTICOSTEROID FOR NASAL USE
ANTIALLERGIC
APOTEX INC.
DATE OF REVISION:
150 SIGNET DRIVE
JULY 27, 2017
TORONTO ONTARIO
M9L 1T9
CONTROL NO.: 206051
Page 2 of 26
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
................................................................ 3
SUMMARY PRODUCT INFORMATION
.................................................................................
3
INDICATIONS AND CLINICAL USE
.......................................................................................
3
CONTRAINDICATIONS
..........................................................................................................
3
WARNINGS AND PRECAUTIONS
.........................................................................................
4
ADVERSE REACTIONS
.........................................................................................................
6
DRUG INTERACTIONS
..........................................................................................................
8
DOSAGE AND ADMINISTRATION
.........................................................................................
9
OVERDOSAGE
.......................................................................................................................
9
ACTION AND CLINICAL PHARMACOLOGY
.......................................................................
10
STORAGE AND STABILITY
.................................................................................................
11
SPECIAL HANDLING INSTRUCTIONS
................................................................................
11
DOSAGE FORMS, COMPOSITION AND PACKAGING
...................................................... 11
PART II: SCIENTIFIC INFORMATION
......................................................................................
12
PHARMACEUTICAL INFORMATION
...................................................................................
12
CLINICAL
TRIALS...........
Prečítajte si celý dokument
